McMillan Shakespeare's TSR for the year was broadly in line with the market average, at 33%. The silver lining is that the share price is up in the short term, which flies in the face of the annualised loss of 0.4% over the last five years. While 'turnarounds seldom turn' there are green shoots for McMillan Shakespeare. I find it very interesting to look at share price over the long term as a proxy for business performance. But to truly gain insight, we need to consider other information, too. Like risks, for instance. Every company has them, and we've spotted 3 warning signs for McMillan Shakespeare (of which 1 is concerning!) you should know about.